acetyl cysteine and endometrioma

Phase 3

Recruiting

• Conditions: Endometrioma.; Endometriosis of ovary; N80.1

• Registration Number: IRCT20210619051619N1
• Lead Sponsor: Royan Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

Age between 20 and 42 years old
Ultrasound or laparoscopic diagnosis of moderate to sever endometrioma (endometriosis stage III and IV)
Serum AMH levels between 0.7 and 4.5 ng/ml
Standard long GnRH and antagonist ovulation stimulation cycle
Body mass index (BMI) <30 kg/m2

Exclusion Criteria

Non-inclusion criteria: Congenital uterine malformations
Severe male infertility (TESE, PESA)
Past medical history of asthma

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MII oocyte number and quality. Timepoint: Immediately after oocyte puncture. Method of measurement: Observation of oocytes that were mature at the time of oocyte collection.